국내 건강보험심사청구자료에 근거한 다빈도 치료중복 의약품 약효군 분석Analysis of Frequent Therapeutic Duplication Drug Classes Based on National Health Insurance Claimed Data in Korea
- Other Titles
- Analysis of Frequent Therapeutic Duplication Drug Classes Based on National Health Insurance Claimed Data in Korea
- Authors
- 손현순; 이영숙; 최경업; 신현택
- Issue Date
- Dec-2010
- Publisher
- 한국임상약학회
- Keywords
- therapeutic duplication; national claimed data; drug utilization review
- Citation
- 한국임상약학회지, v.20, no.3, pp 262 - 267
- Pages
- 6
- Journal Title
- 한국임상약학회지
- Volume
- 20
- Number
- 3
- Start Page
- 262
- End Page
- 267
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/13356
- ISSN
- 1226-6051
- Abstract
- Therapeutic duplication of prescriptions is the most frequently reported inappropriate drug use in Korea. To prevent significant problems during drug prescribing and dispensing, prospectively, development of standard including drug lists considered as therapeutic duplications for the prioritized drug classes first would be necessary. This study was aimed to analyze frequent drug classes of therapeutic duplications by healthcare providers in clinical practice settings. National health claims data for drug review and reimbursement (1,426,065 prescriptions dated March 19, 2008) were analyzed.
Therapeutic duplication was defined as the prescription including more than 2 ingredients belonging to the same KFDA drug classification numbers that considered to have therapeutic similarities. The following 3 drug classes were mostly frequent therapeutic duplication classes: 114 anti-pyretics, analgesics and anti-inflammatory drugs; 117 drugs for psycho-nervous system; 141 Antihistamines. About 3.5% of overall prescriptions analyzed showed therapeutic duplications.
This result might be starting step to develop DUR therapeutic duplication standard.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/13356)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.